Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13,838,977
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
6,135,684
-
Shares change
-
+96,258
-
Total reported value, excl. options
-
$60,069,000
-
Value change
-
+$1,291,252
-
Number of buys
-
17
-
Number of sells
-
-21
-
Price
-
$9.79
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q1 2019
47 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q1 2019.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,135,684 shares
of 13,838,977 outstanding shares and own 44% of the company stock.
Largest 10 shareholders include Battery Partners IX, LLC (2,011,882 shares), NEA Management Company, LLC (1,562,500 shares), CADENCE CAPITAL MANAGEMENT LLC (273,335 shares), VANGUARD GROUP INC (265,122 shares), Granite Investment Partners, LLC (192,527 shares), RENAISSANCE TECHNOLOGIES LLC (191,946 shares), PERKINS CAPITAL MANAGEMENT INC (174,700 shares), INGALLS & SNYDER LLC (158,648 shares), DIMENSIONAL FUND ADVISORS LP (133,170 shares), and Schonfeld Strategic Advisors LLC (126,900 shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.